We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-1.92%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.89B
AUM Growth
-$88.4M
Cap. Flow
-$42.7M
Cap. Flow %
-2.25%
Top 10 Hldgs %
59.31%
Holding
45
New
1
Increased
10
Reduced
27
Closed
1

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$62.2M
2
ASML icon
ASML
ASML
+$14.9M
3
NVDA icon
NVIDIA
NVDA
+$12.2M
4
HON icon
Honeywell
HON
+$9.87M
5
CL icon
Colgate-Palmolive
CL
+$6.01M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$63.6M
2
AAPL icon
Apple
AAPL
+$17.8M
3
BDX icon
Becton Dickinson
BDX
+$17.4M
4
ORCL icon
Oracle
ORCL
+$12.4M
5
JQUA icon
JPMorgan US Quality Factor ETF
JQUA
+$7.33M

Sector Composition

Rank Sector Weight
1 Technology 20.74%
2 Healthcare 16.73%
3 Consumer Staples 14.66%
4 Communication Services 13.96%
5 Financials 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.09T
$148M 7.83%
278,541
-71
-0% -$34.5K
UL icon
2
Unilever
UL
$133B
$134M 7.1%
2,006,612
+27,280
+1% +$1.76M
DIS icon
3
Walt Disney
DIS
$178B
$134M 7.08%
1,358,068
+10,335
+0.8% +$1.11M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.2T
$129M 6.83%
836,300
-3,296
-0.4% -$598K
MSFT icon
5
Microsoft
MSFT
$3.66T
$121M 6.36%
321,058
+7,601
+2% +$3.1M
MDT icon
6
Medtronic
MDT
$116B
$106M 5.6%
1,181,178
+50,920
+5% +$4.56M
NVO
7
Novo Nordisk
NVO
$203B
$101M 5.33%
1,454,160
+753,526
+108% +$62.2M
JNJ icon
8
Johnson & Johnson
JNJ
$629B
$83.7M 4.42%
504,419
-15,933
-3% -$2.49M
RTX icon
9
RTX Corp
RTX
$300B
$82.8M 4.37%
625,274
-501,844
-45% -$63.6M
ORCL icon
10
Oracle
ORCL
$442B
$82.7M 4.37%
591,727
-76,457
-11% -$12.4M
GD icon
11
General Dynamics
GD
$107B
$58.6M 3.09%
214,865
-18,087
-8% -$4.7M
V icon
12
Visa
V
$671B
$58.2M 3.07%
166,155
-9,522
-5% -$3.22M
AAPL icon
13
Apple
AAPL
$4.41T
$52.7M 2.78%
237,442
-76,699
-24% -$17.8M
SBUX icon
14
Starbucks
SBUX
$124B
$49.9M 2.63%
508,486
-21,991
-4% -$2.27M
ASML icon
15
ASML
ASML
$695B
$49.6M 2.62%
74,805
+20,454
+38% +$14.9M
ACN icon
16
Accenture
ACN
$110B
$47M 2.48%
150,639
-5,037
-3% -$1.78M
CHRW icon
17
C.H. Robinson
CHRW
$17.1B
$46.5M 2.46%
454,427
-20,468
-4% -$2.07M
NKE icon
18
Nike
NKE
$60.1B
$41.5M 2.19%
654,313
-2,587
-0.4% -$190K
HD icon
19
Home Depot
HD
$342B
$37.1M 1.96%
101,332
-4,527
-4% -$1.76M
DEO icon
20
Diageo
DEO
$52.2B
$35.9M 1.9%
342,699
+9,266
+3% +$1.05M
WMT icon
21
Walmart Inc
WMT
$923B
$35.4M 1.87%
402,731
-65,587
-14% -$6.15M
PG icon
22
Procter & Gamble
PG
$335B
$27.9M 1.47%
163,513
-3,180
-2% -$533K
ADBE icon
23
Adobe
ADBE
$103B
$26.9M 1.42%
70,185
-1,951
-3% -$837K
LLY icon
24
Eli Lilly
LLY
$1.09T
$25.1M 1.33%
30,436
-871
-3% -$725K
PEP icon
25
PepsiCo
PEP
$189B
$24.8M 1.31%
165,530
+586
+0.4% +$87.2K

Similar funds

Saratoga Research & Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, Saratoga Research & Investment Management held 45 positions worth $1.89B, down 4.5% from $1.98B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 4.4%. Saratoga Research & Investment Management opened 1 new position and exited 1, leaving the 45-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Saratoga Research & Investment Management's largest Q1 2025 buy was NVIDIA: 96,265 shares worth $10.4M.
  • Saratoga Research & Investment Management added most to Novo Nordisk in Q1 2025, an estimated $62.2M increase.
  • Saratoga Research & Investment Management's biggest Q1 2025 reduction was RTX Corp, cutting an estimated $63.6M.
  • Saratoga Research & Investment Management fully exited Biogen in Q1 2025, selling an estimated $221K.
  • Saratoga Research & Investment Management's ten largest holdings make up 59% of its $1.89B portfolio in Q1 2025.
  • Saratoga Research & Investment Management opened 1 new position and closed 1 in Q1 2025.
  • Saratoga Research & Investment Management's portfolio value fell 4.5% quarter-over-quarter to $1.89B.

Based on Saratoga Research & Investment Management's 13F filing for Q1 2025, filed 12 May 2025.